1. |
POULTER N, Global risk of cardiovascular disease, Heart[J].2003, 89(suppl 2):ii2-ii5.
|
2. |
CHYU K Y, SHAH P K. Emerging therapies for atherosclerosis prevention and management[J]. Cardiol Clin, 2011, 29(1):123-135.
|
3. |
FLÓREZ A F, PARK D, BHAK J, et al. Protein network prediction and topological analysis in Leishmania major as a tool for drug target selection[J]. BMC Bioinformatics, 2010, 11(1):484.
|
4. |
ALFARANO C, ANDRADE C E, ANTHONY K, et al. The biomolecular interaction network database and related tools 2005 update[J]. Nucleic Acids Res, 2005, 33(Database issue):D418-D424.
|
5. |
SHANNON P, MARKIEL A, OZIER O, et al. Cytoscape:a software environment for integrated models of biomolecular interaction networks[J]. Genome Res, 2003, 13(11):2498-2504.
|
6. |
ASSENOV Y, RAMÍREZ F, SCHELHORN S E, et al. Computing topological parameters of biological networks[J]. Bioinformatics, 2008, 24(2):282-284.
|
7. |
WU Jianmin, MAO Xizeng, CAI Tao, et al. KOBAS server:a web-based platform for automated annotation and pathway identification[J]. Nucleic Acids Res, 2006, 34(suppl. 2):W720-W724.
|
8. |
DAVIES S S, ROBERTS L J. F2-isoprostanes as an indicator and risk factor for coronary heart disease[J]. Free Radic Biol Med, 2011, 50(5):559-566.
|
9. |
SHERVA R, FORD C E, ECKFELDT J H, et al. Pharmacogenetic effect of the stromelysin (MMP3) polymorphism on stroke risk in relation to antihypertensive treatment:the genetics of hypertension associated treatment study[J]. Stroke, 2011, 42(2):330-335.
|
10. |
SCHWARTZ R S, BORISSOFF J I, SPRONK H M, et al., The hemostatic system as a modulator of atherosclerosis, New Engl J Med[J].2011, 364(18):1746-1760.
|
11. |
WANG H, YIN Y, LI W, et al., Over-expression of PDGFR-beta promotes PDGF-induced proliferation, migration, and angiogenesis of EPCs through PI3K/Akt signaling pathway, PloS One[J].2012, 7(2):e30503.
|
12. |
FERRARA N, KERBEL R S, Angiogenesis as a therapeutic target, Nature[J].2005, 438(7070):967-974.
|
13. |
FREITAS W M, QUAGLIA L A, SANTOS S N, et al. Association of systemic inflammatory activity with coronary and carotid atherosclerosis in the very elderly[J]. Atherosclerosis, 2011, 216(1):212-216.
|
14. |
STOUT R, Diabetes and atherosclerosis, Biomed Pharmacother[J].1993, 47(1):1-2.
|
15. |
NASCIMENTO I S, QUAIO C R, SINICATO N A, et al. Aspects of atherosclerosis and metabolic syndrome in lupus erythematosus[J]. Acta Reumatol Port, 2010, 35(3):294-300.
|
16. |
HANSSON G K, HERMANSSON A. The immune system in atherosclerosis[J]. Nat Immunol, 2011, 12(3):204-212.
|